Back to top

rating-upgrade: Archive

Zacks Equity Research

OPENLANE (KAR) Upgraded to Buy: Here's Why

OPENLANE (KAR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

KARNegative Net Change

Zacks Equity Research

All You Need to Know About AvePoint (AVPT) Rating Upgrade to Buy

AvePoint (AVPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AVPTNegative Net Change

Zacks Equity Research

Qifu Technology, Inc. (QFIN) Upgraded to Strong Buy: Here's What You Should Know

Qifu Technology, Inc. (QFIN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

QFINNegative Net Change

Zacks Equity Research

H20 (HTO) Moves to Strong Buy: Rationale Behind the Upgrade

H20 (HTO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

HTOPositive Net Change

Zacks Equity Research

All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy

Nuvation Bio (NUVB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NUVBNegative Net Change

Zacks Equity Research

Post Holdings (POST) Upgraded to Buy: Here's Why

Post Holdings (POST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

POSTPositive Net Change

Zacks Equity Research

Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know

Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PACBPositive Net Change

Zacks Equity Research

What Makes Montrose Environmental (MEG) a New Strong Buy Stock

Montrose Environmental (MEG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MEGPositive Net Change

Zacks Equity Research

What Makes Enel (ENLAY) a New Buy Stock

Enel (ENLAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ENLAYNo Net Change

Zacks Equity Research

All You Need to Know About Aramark (ARMK) Rating Upgrade to Buy

Aramark (ARMK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ARMKPositive Net Change

Zacks Equity Research

First Advantage (FA) Upgraded to Buy: Here's Why

First Advantage (FA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FANegative Net Change

Zacks Equity Research

Alignment Healthcare (ALHC) Upgraded to Buy: Here's What You Should Know

Alignment Healthcare (ALHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ALHCPositive Net Change

Zacks Equity Research

All You Need to Know About MPLX LP (MPLX) Rating Upgrade to Buy

MPLX LP (MPLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MPLXNegative Net Change

Zacks Equity Research

All You Need to Know About Omnicom (OMC) Rating Upgrade to Buy

Omnicom (OMC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

OMCPositive Net Change

Zacks Equity Research

All You Need to Know About Forrester Research (FORR) Rating Upgrade to Buy

Forrester Research (FORR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FORRNegative Net Change

Zacks Equity Research

COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why

COMPASS Pathways (CMPS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CMPSPositive Net Change

Zacks Equity Research

Bancolombia (CIB) Upgraded to Strong Buy: Here's Why

Bancolombia (CIB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CIBPositive Net Change

Zacks Equity Research

All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy

Si-Bone (SIBN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SIBNNegative Net Change

Zacks Equity Research

All You Need to Know About Associated Banc-Corp (ASB) Rating Upgrade to Buy

Associated Banc-Corp (ASB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ASBPositive Net Change

Zacks Equity Research

Evolv Technologies (EVLV) Upgraded to Strong Buy: Here's What You Should Know

Evolv Technologies (EVLV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

EVLVPositive Net Change

Zacks Equity Research

What Makes Labcorp (LH) a New Buy Stock

Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LHPositive Net Change

Zacks Equity Research

All You Need to Know About Aviva (AVVIY) Rating Upgrade to Buy

Aviva (AVVIY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AVVIYPositive Net Change

Zacks Equity Research

Palantir Technologies (PLTR) Upgraded to Buy: Here's What You Should Know

Palantir Technologies (PLTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PLTRPositive Net Change

Zacks Equity Research

What Makes Exact Sciences (EXAS) a New Buy Stock

Exact Sciences (EXAS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

EXASNegative Net Change

Zacks Equity Research

All You Need to Know About Byline Bancorp (BY) Rating Upgrade to Buy

Byline Bancorp (BY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BYPositive Net Change